Skip to content

ADMA Biologics ADMA Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin57.4%+5.9pp51.5%+17.0pp34.4%+11.6pp22.9%+21.4pp
Operating margin37.5%+4.9pp32.6%+24.2pp8.4%+33.9pp-25.5%+46.6pp
Net margin28.8%-17.6pp46.4%+57.3pp-10.9%+31.8pp-42.8%+45.7pp
Returns
Return on equity35.6%-46.1pp81.6%+101pp-19.7%+25.3pp-45%+17.5pp
Return on invested capital38.6%-27.1pp65.8%+40.6pp25.2%+70.1pp-44.9%+6.2pp
Efficiency
Asset turnover0.9×-0.1×+0.3×0.8×+0.3×0.5×+0.2×
Liquidity
Current ratio6.7×+0.7×+0.8×5.2×-1.7×6.9×0.0×
Leverage
Debt-to-equity0.2×-0.1×0.2×+0.2×0.1×0.0×0.1×0.0×
Net debt / EBITDA-0×+0.1×-0.1×+1.2×-1.4×
Per Share
Book value per share$1.95+35.9%$1.43+138%$0.60-21.4%$0.77-24.1%
Valuation
Market capitalization$4.34B+7.1%$4.05B+297%$1.02B+19.2%$857.1M+210%
Price / earnings29.5×+9.0×20.5×
Price / sales8.5×-1.0×9.5×+5.6×-1.6×5.6×+2.2×
Price / book9.1×-2.5×11.6×+4.1×7.6×+1.9×5.6×+3.7×
EV / EBITDA21.7×-5.8×27.5×-6.1×33.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ADMA Biologics's profit margins?
ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
Where do ADMA Biologics's ratios come from?
Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.